The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global organ-on-chip market was valued at US$ 34.52 Million in 2021.
We expect the global organ-on-chip market to exhibit a CAGR of 31.70% during 2022-2027.
The growing demand for lung and kidney-based organ culture devices, along with the rising advancements in cell biology, microfabrication, and microfluidics, are primarily driving the global organ-on-chip market.
The sudden outbreak of the COVID-19 pandemic has led to the rising popularity for organ-on-chips technology for developing drugs and their screening to treat the coronavirus-infected patients.
Based on the type, the global organ-on-chip market can be categorized into liver, heart, lung, kidney, and others. Among these, lung accounts for the majority of the global market share.
Based on the application, the global organ-on-chip market has been segregated into physiological model development, drug discovery, and toxicology research. Currently, drug discovery holds the largest market share.
Based on the end use, the global organ-on-chip market can be bifurcated into pharmaceutical and biotechnology companies, academic and research institutes, cosmetics industry, and others. Among these, pharmaceutical and biotechnology companies exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global organ-on-chip market include Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc., and TissUse GmbH.
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at